OBJECTIVES: We sought to evaluate the contemporary results after repair of a complete atrioventricular septal defect and to determine the factors associated with suboptimal outcomes. METHODS: The demographic, procedural, and outcome data were obtained within 1 and 6 months after repair of a complete atrioventricular septal defect in 120 children in a multicenter observational study from June 2004 to 2006. RESULTS: The median age at surgery was 3.7 months (range, 9 days to 1.1 years). The type of surgical repair was a single patch (18%), double patch (72%), and a single atrial septal defect patch with primary ventricular septal defect closure (10%). The incidence of residual septal defects and the degree of left atrioventricular valve regurgitation (LAVVR) did not differ by repair type. The median interval of intensive care stay were 4 days, ventilation use 2 days, and total hospitalization 8 days. All were independent of the presence of trisomy 21 (80% of the cohort). The in-hospital mortality rate was 2.5% (3/120). The overall 6-month mortality rate was 4% (5/120). The presence of associated anomalies and younger age at surgery were independently associated with a longer hospital stay. The age at repair was not associated with residual ventricular septal defect or moderate or greater LAVVR at 6 months. Moderate or greater LAVVR occurred in 22% at 6 months, and the strongest predictor for this was moderate or greater LAVVR at 1 month (odds ratio, 6.9; 95% confidence interval, 2.2-21.7; P < .001). CONCLUSIONS: The outcomes after repair of complete atrioventricular septal defect did not differ by repair type or the presence of trisomy 21. An earlier age at surgery was associated with increased resource use but had no association with the incidence of residual ventricular septal defect or significant LAVVR.
OBJECTIVES: We sought to evaluate the contemporary results after repair of a complete atrioventricular septal defect and to determine the factors associated with suboptimal outcomes. METHODS: The demographic, procedural, and outcome data were obtained within 1 and 6 months after repair of a complete atrioventricular septal defect in 120 children in a multicenter observational study from June 2004 to 2006. RESULTS: The median age at surgery was 3.7 months (range, 9 days to 1.1 years). The type of surgical repair was a single patch (18%), double patch (72%), and a single atrial septal defect patch with primary ventricular septal defect closure (10%). The incidence of residual septal defects and the degree of left atrioventricular valve regurgitation (LAVVR) did not differ by repair type. The median interval of intensive care stay were 4 days, ventilation use 2 days, and total hospitalization 8 days. All were independent of the presence of trisomy 21 (80% of the cohort). The in-hospital mortality rate was 2.5% (3/120). The overall 6-month mortality rate was 4% (5/120). The presence of associated anomalies and younger age at surgery were independently associated with a longer hospital stay. The age at repair was not associated with residual ventricular septal defect or moderate or greater LAVVR at 6 months. Moderate or greater LAVVR occurred in 22% at 6 months, and the strongest predictor for this was moderate or greater LAVVR at 1 month (odds ratio, 6.9; 95% confidence interval, 2.2-21.7; P < .001). CONCLUSIONS: The outcomes after repair of complete atrioventricular septal defect did not differ by repair type or the presence of trisomy 21. An earlier age at surgery was associated with increased resource use but had no association with the incidence of residual ventricular septal defect or significant LAVVR.
Authors: Luis Alesandro Larrazabal; Pedro J del Nido; Kathy J Jenkins; Kimberlee Gauvreau; Ronald Lacro; Steve D Colan; Frank Pigula; Oscar J Benavidez; Francis Fynn-Thompson; John E Mayer; Emile A Bacha Journal: Ann Thorac Surg Date: 2007-01 Impact factor: 4.330
Authors: R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson Journal: Adv Data Date: 2000-06-08
Authors: Roberto Formigari; Roberto M Di Donato; Gaetano Gargiulo; Duccio Di Carlo; Cristiana Feltri; Fernando M Picchio; Bruno Marino Journal: Ann Thorac Surg Date: 2004-08 Impact factor: 4.330
Authors: Carl L Backer; Robert D Stewart; Frédérique Bailliard; Angela M Kelle; Catherine L Webb; Constantine Mavroudis Journal: Ann Thorac Surg Date: 2007-12 Impact factor: 4.330
Authors: G Stellin; V L Vida; O Milanesi; G Rizzoli; M Rubino; M A Padalino; R Bonato; D Casarotto Journal: Eur J Cardiothorac Surg Date: 2003-02 Impact factor: 4.191
Authors: Muralidhar Padala; Nikolay V Vasilyev; James W Owen; Jorge H Jimenez; Lakshmi P Dasi; Pedro J del Nido; Ajit P Yoganathan Journal: J Thorac Cardiovasc Surg Date: 2008-09-14 Impact factor: 5.209
Authors: Angela P Presson; Ginger Partyka; Kristin M Jensen; Owen J Devine; Sonja A Rasmussen; Linda L McCabe; Edward R B McCabe Journal: J Pediatr Date: 2013-07-23 Impact factor: 4.406
Authors: Norihiro Kondo; Takashi Shuto; Jeremy R McGarvey; Kevin J Koomalsingh; Manabu Takebe; Robert C Gorman; Joseph H Gorman; Matthew J Gillespie Journal: Ann Thorac Surg Date: 2012-03 Impact factor: 4.330
Authors: James D St Louis; Upinder Jodhka; Jeffrey P Jacobs; Xia He; Kevin D Hill; Sara K Pasquali; Marshall L Jacobs Journal: J Thorac Cardiovasc Surg Date: 2014-07-21 Impact factor: 5.209
Authors: Takashi Shuto; Norihiro Kondo; Yoav Dori; Kevin J Koomalsingh; Andrew C Glatz; Jonathan J Rome; Joseph H Gorman; Robert C Gorman; Matthew J Gillespie Journal: J Am Coll Cardiol Date: 2011-12-06 Impact factor: 24.094
Authors: Aditya K Kaza; Steven D Colan; James Jaggers; Minmin Lu; Andrew M Atz; Lynn A Sleeper; Brian W McCrindle; Linda M Lambert; Renee Margossian; Ronald V Lacro; Marc E Richmond; Shobha Natarajan; L Luann Minich Journal: Ann Thorac Surg Date: 2011-08-26 Impact factor: 4.330
Authors: Jennifer K Peterson; Shaun P Setty; Jessica H Knight; Amanda S Thomas; James H Moller; Lazaros K Kochilas Journal: Congenit Heart Dis Date: 2019-07-22 Impact factor: 2.007
Authors: Danielle S Burstein; Patrick E Gray; Heather M Griffis; Andrew C Glatz; Meryl S Cohen; J William Gaynor; David J Goldberg Journal: Pediatr Cardiol Date: 2019-05-07 Impact factor: 1.655